Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GR

OBJECTIVE: According to current guidelines, there is no clear second-line treatment for advanced liver cancer. In practice, clinicians have attempted to use thalidomide(TLD) combined with transcatheter arterial chemoembolization (TACE) for treating liver cancer. This study aims to assess the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenjie, Wang, Dandan, Huang, Litao, Chen, Yue, Wen, Shu, Hong, Qi, Kang, Deying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171403/
https://www.ncbi.nlm.nih.gov/pubmed/30139041
http://dx.doi.org/10.22034/APJCP.2018.19.8.2043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171403/
https://www.ncbi.nlm.nih.gov/pubmed/30139041
http://dx.doi.org/10.22034/APJCP.2018.19.8.2043

Ejemplares similares